Relay Therapeutics, Inc. (RLAY) Q4 2024 Annual Earnings
RLAY·Reported February 26, 2025·After market close
Diluted EPS came in at $-0.45, beat the $-0.57 consensus by $0.12.
Diluted EPS
$-0.45beat by $0.12
Consensus: $-0.57
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Relay Therapeutics, Inc.'s Q4 2024 earnings report.
Relay Therapeutics, Inc. (RLAY) reported Q4 2024 earnings on February 26, 2025 after market close.
Relay Therapeutics, Inc. reported diluted EPS of $-0.45 for Q4 2024.
EPS beat the consensus estimate of $-0.57 by $0.12.
You can read the 10-K periodic report (0000950170-25-027756) directly on SEC EDGAR. The filing index links above go to sec.gov.